Celularity (CELU) Gross Profit (2020 - 2026)
Celularity (CELU) recorded Gross Profit of $3.09 million in Q2 2026, up 524.5% from $494,000 a year earlier and up 28.9% from the prior quarter.
Powered by 
Analysis
Celularity (CELU) Gross Profit (2020 - 2026) Analysis & Trends
On a TTM basis, Celularity's Gross Profit came in at $3.59 million as of Jun 30, 2026, down 85.4% year-over-year; for FY2025, it was $6.48 million, down 83.5% from FY2024.
- Annual Gross Profit has a five-year compound annual growth rate of -7.1% (FY2020 to FY2025).
- Across earlier years, Gross Profit came in at $39.23 million in FY2024 (+480.8%), $6.76 million in FY2023, -$1.69 million in FY2022 and $11.68 million in FY2021 (+25.0%).
- The Q2 2026 figure is the highest quarterly Gross Profit since Q1 2025.
- On a year-over-year basis, Gross Profit rose in two of the last six quarters, with growth averaging 96.1%.
- Peak year-over-year performance for Gross Profit in the last five years was growth of 575.0% in Q1 2024, against a decline of 95.1% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.39 million (Q1 2026), -$3.27 million (Q4 2025) and $1.38 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Celularity | 30.75 Mn | 23.50 Mn | 3.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.09 Mn |
| Mar 31, 2026 | 2.39 Mn |
| Dec 31, 2025 | -3.27 Mn |
| Sep 30, 2025 | 1.38 Mn |
| Jun 30, 2025 | 494,000.00 |
| Mar 31, 2025 | 7.87 Mn |
| Dec 31, 2024 | 10.79 Mn |
| Sep 30, 2024 | 5.41 Mn |
| Jun 30, 2024 | 9.99 Mn |
| Mar 31, 2024 | 13.04 Mn |
| Dec 31, 2023 | 2.50 Mn |
| Sep 30, 2023 | 184,000.00 |
| Jun 30, 2023 | 2.14 Mn |
| Mar 31, 2023 | 1.93 Mn |
| Dec 31, 2022 | -1.12 Mn |
| Sep 30, 2022 | -3.08 Mn |
| Jun 30, 2022 | 597,000.00 |
| Mar 31, 2022 | 1.91 Mn |
| Dec 31, 2021 | 196,000.00 |
| Sep 30, 2021 | 8.31 Mn |
API Access
Celularity Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=CELU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "CELU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=CELU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();